Challenges in the Care of Patients with AKI Receiving Outpatient Dialysis: AKINow Recovery Workgroup Report.


Journal

Kidney360
ISSN: 2641-7650
Titre abrégé: Kidney360
Pays: United States
ID NLM: 101766381

Informations de publication

Date de publication:
06 Dec 2023
Historique:
received: 03 04 2023
accepted: 29 11 2023
medline: 6 12 2023
pubmed: 6 12 2023
entrez: 6 12 2023
Statut: aheadofprint

Résumé

Up to one-third of survivors of acute kidney injury that required dialysis (AKI-D) during a hospitalization remain dialysis dependent at hospital discharge. Of these, 20 to 60%, depending on the clinical setting, eventually recover enough kidney function to stop dialysis and the remainder progress to end-stage kidney disease. To describe the challenges facing those still receiving dialysis on discharge, the AKINOW Committee conducted a group discussion composed of 59 participants including physicians, advanced practitioners, nurses, pharmacists, and patients. The discussion was framed by a patient who described gaps in care delivery at different transition points and miscommunication between care team members and the patient. Group discussions collected patient perspectives of: 1) being often scared and uncertain about what is happening to and around them and 2) the importance of effective and timely communication, a comfortable physical setting, and attentive and caring healthcare providers for a quality healthcare experience. Provider perspectives included: 1) the recognition of the lack of evidence-based practices and quality indicators, the significant variability in current care models, and the uncertain reimbursement incentives focused on kidney recovery and 2) the urgency to address communication barriers among hospital providers and outpatient facilities. The workgroup identified key areas for future research and policy change to: 1) improve communication among hospital providers, dialysis units and patients/care partners; 2) develop tools for risk-classification, sub-phenotyping and augmented clinical decision support; 3) improve education to providers, staff, and patients/care partners; 4) identify best practices to improve relevant outcomes; 5) validate quality indicators; and 6) assess the impact of social determinants of health on outcomes. We urge all stakeholders involved in the process of AKI-D care to align goals and work together to fill knowledge gaps and optimize the care to this highly vulnerable patient population.

Sections du résumé

BACKGROUND BACKGROUND
Up to one-third of survivors of acute kidney injury that required dialysis (AKI-D) during a hospitalization remain dialysis dependent at hospital discharge. Of these, 20 to 60%, depending on the clinical setting, eventually recover enough kidney function to stop dialysis and the remainder progress to end-stage kidney disease.
METHODS METHODS
To describe the challenges facing those still receiving dialysis on discharge, the AKINOW Committee conducted a group discussion composed of 59 participants including physicians, advanced practitioners, nurses, pharmacists, and patients. The discussion was framed by a patient who described gaps in care delivery at different transition points and miscommunication between care team members and the patient.
RESULTS RESULTS
Group discussions collected patient perspectives of: 1) being often scared and uncertain about what is happening to and around them and 2) the importance of effective and timely communication, a comfortable physical setting, and attentive and caring healthcare providers for a quality healthcare experience. Provider perspectives included: 1) the recognition of the lack of evidence-based practices and quality indicators, the significant variability in current care models, and the uncertain reimbursement incentives focused on kidney recovery and 2) the urgency to address communication barriers among hospital providers and outpatient facilities.
CONCLUSIONS CONCLUSIONS
The workgroup identified key areas for future research and policy change to: 1) improve communication among hospital providers, dialysis units and patients/care partners; 2) develop tools for risk-classification, sub-phenotyping and augmented clinical decision support; 3) improve education to providers, staff, and patients/care partners; 4) identify best practices to improve relevant outcomes; 5) validate quality indicators; and 6) assess the impact of social determinants of health on outcomes. We urge all stakeholders involved in the process of AKI-D care to align goals and work together to fill knowledge gaps and optimize the care to this highly vulnerable patient population.

Identifiants

pubmed: 38055734
doi: 10.34067/KID.0000000000000332
pii: 02200512-990000000-00298
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : R01DK128208, R01DK133539, U01DK12998, P30 DK079337
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01DK128208, R01DK133539, U01DK12998, P30 DK079337
Pays : United States

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology.

Auteurs

Javier A Neyra (JA)

Department of Medicine, Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Leslie Gewin (L)

Department of Medicine, Division of Nephrology, Washington University in St. Louis, St. Louis, Missouri, USA.

Jia H Ng (JH)

Department of Medicine, Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine, Hempstead, New York, USA.

Erin F Barreto (EF)

Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.

Bonnie Freshly (B)

American Society of Nephrology Alliance for Kidney Health.

Jeff Willett (J)

American Society of Nephrology Alliance for Kidney Health.

Emaad M Abdel-Rahman (EM)

Department of Medicine, Division of Nephrology, University of Virginia, Charlottesville, VA.

Ian McCoy (I)

Department of Medicine, Division of Nephrology, University of California, San Francisco, CA.

Yuenting D Kwong (YD)

Department of Medicine, Division of Nephrology, University of California, San Francisco, CA.

Samuel A Silver (SA)

Division of Nephrology, Kingston Health Sciences Center, Queen's University, Kingston, Ontario, Canada.

Jorge Cerda (J)

Department of Medicine, Division of Nephrology, Albany Medical College, Albany, New York.

Anitha Vijayan (A)

Department of Medicine, Division of Nephrology, Washington University in St. Louis, St. Louis, Missouri, USA.

Classifications MeSH